If directly targeting YAP, TAZ, or TEADs proves difficult or toxic, alternative approaches could target either cancer-specific pathways that promote YAP/TAZ activity in cancer cells, or the pro-tumorigenic and pro-metastatic target genes induced by YAP and TAZ. The gene discussed is WWTR1; the disease is cancer.